Clinical trial
Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
NCT07655570 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 19, 2026
- Completion date
- May 11, 2029
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous angiosarcoma